Literature DB >> 25677864

Association between prolactin and thyroid hormones with severity of psychopathology and suicide risk in drug free male schizophrenia.

Jancy Jose1, H Nandeesha1, Shivanand Kattimani1, Kavitha Meiyappan1, Siddharth Sarkar1, Devanarayanan Sivasankar1.   

Abstract

BACKGROUND: Hormonal deregulation is associated with suicidal risk in various psychiatric disorders. Thyroid hormones and prolactin play a role in the pathophysiology of schizophrenia. The present study aimed to analyze thyroid hormones and prolactin levels in patients with schizophrenia, and to explore its association with disease severity and suicide risk.
METHODS: Thirty-eight cases and 38 controls were included in the study. Serum thyroid hormones and prolactin were estimated in all the subjects. Disease severity was assessed using the Positive and Negative Syndrome Scale and suicidal ideations were assessed using the Columbia Suicide Severity Rating Scale.
RESULTS: Serum prolactin (p=0.004) and free T4 (p=0.029) were significantly elevated in the schizophrenia group as compared to controls. Serum prolactin was significantly associated with higher negative symptom scores (r=0.418, p=0.008), but not positive symptoms or general psychopathology of schizophrenia. Thyroid hormones were not associated with disease severity scores. Suicidal ideas were more common in schizophrenia patients with higher free T4 (p=0.011).
CONCLUSION: Prolactin and free T4 were increased in patients with schizophrenia as compared to controls. Suicidal ideation was associated with increased free T4, but not prolactin levels.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Prolactin; Psychopathology; Schizophrenia; Suicide; Thyroxin; Triiodothyronine

Mesh:

Substances:

Year:  2015        PMID: 25677864     DOI: 10.1016/j.cca.2015.02.003

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

Review 1.  Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.

Authors:  Meritxell Tost; José Antonio Monreal; Antonio Armario; Juan David Barbero; Jesús Cobo; Clemente García-Rizo; Miquel Bioque; Judith Usall; Elena Huerta-Ramos; Virginia Soria; Javier Labad
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859

Review 2.  Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine-Immune Therapeutic Mechanisms and Clinical Implications.

Authors:  Milagros Rojas; Daniela Ariza; Ángel Ortega; Manuel E Riaño-Garzón; Mervin Chávez-Castillo; José Luis Pérez; Lorena Cudris-Torres; María Judith Bautista; Oscar Medina-Ortiz; Joselyn Rojas-Quintero; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

3.  Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study.

Authors:  Chao Li; Zhenchun Shi; Jiacui Ji; Gengyun Niu; Zengxun Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-10       Impact factor: 2.570

4.  Multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidality.

Authors:  Renato Polimanti; Daniel F Levey; Gita A Pathak; Frank R Wendt; Yaira Z Nunez; Robert J Ursano; Ronald C Kessler; Henry R Kranzler; Murray B Stein; Joel Gelernter
Journal:  Transl Psychiatry       Date:  2021-01-11       Impact factor: 6.222

5.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

Review 6.  Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.

Authors:  C Gragnoli; G M Reeves; J Reazer; T T Postolache
Journal:  Transl Psychiatry       Date:  2016-04-19       Impact factor: 6.222

7.  Functional Status of Hypothalamic-Pituitary-Thyroid and Hypothalamic-Pituitary-Adrenal Axes in Hospitalized Schizophrenics in Shanghai.

Authors:  Yuncheng Zhu; Haifeng Ji; Lily Tao; Qing Cai; Fang Wang; Weidong Ji; Guohai Li; Yiru Fang
Journal:  Front Psychiatry       Date:  2020-02-27       Impact factor: 4.157

8.  Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome.

Authors:  Elena G Kornetova; Alexander N Kornetov; Irina A Mednova; Olga A Lobacheva; Valeria I Gerasimova; Viktoria V Dubrovskaya; Ivan V Tolmachev; Arkadiy V Semke; Anton J M Loonen; Nikolay A Bokhan; Svetlana A Ivanova
Journal:  Diagnostics (Basel)       Date:  2020-09-10

Review 9.  Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis.

Authors:  Freddy J K Toloza; Yuanjie Mao; Lakshmi Menon; Gemy George; Madhura Borikar; Soumya Thumma; Hooman Motahari; Patricia Erwin; Richard Owen; Spyridoula Maraka
Journal:  Medicina (Kaunas)       Date:  2021-07-15       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.